Skip to content

A parallel-group, randomized controlled trial into the effectiveness of Mindfulness-Based Compassionate Living (MBCL) compared to treatment-as-usual in recurrent depression: Trial design and protocol.

Rhoda Schuling, Marloes J. Huijbers, Hiske Van Ravesteijn, Rogier Donders, Willem Kuyken, Anne E. M. Speckens

Contemporary Clinical Trials September 2016 DOI: 10.1016/j.cct.2016.07.014 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial (study protocol) Peer reviewed
Population Patients with recurrent depressive episodes who completed an MBCT course in the past
Interventions Mindfulness-Based Compassionate Living (MBCL) treatment as usual (TAU)
Duration Assessments at baseline, post-treatment, and six months follow-up
Measures Beck Depression Inventory-II (BDI-II), DSM-IV depressive disorder, rumination, self-compassion, mindfulness skills, positive affect, quality of life, experiential avoidance, fear of self-compassion
Topics Depression Meditation
Keywords Randomized controlled trial Recurrent depression
Registration NCT02059200
Key findings The protocol proposes that adding Mindfulness-Based Compassionate Living to treatment as usual, compared with treatment as usual alone, may reduce residual depressive symptoms in patients with recurrent depression who previously completed MBCT. The authors note that no prior research has tested compassion training following MBCT in this population, and the trial's primary outcome is BDI-II depressive symptom severity at post-treatment.

Abstract

Mindfulness Based Cognitive Therapy (MBCT) has been shown to reduce the risk of relapse in patients with recurrent depression, but relapse rates remain high. To further improve outcome for this group of patients, follow-up interventions may be needed. Compassion training focuses explicitly on developing self-compassion, one of the putative working mechanisms of MBCT. No previous research has been done on the effectiveness of compassion training following MBCT in patients with recurrent depression. To investigate the effectiveness of Mindfulness-Based Compassionate Living (MBCL) in reducing (residual) depressive symptoms in patients with recurrent depression who previously participated in MBCT. A randomized controlled trial comparing MBCL in addition to treatment as usual (TAU) with TAU only, in patients suffering from recurrent depressive episodes who completed an MBCT course in the past. Assessments will take place at baseline, post-treatment and at six months follow-up. After the control period, patients randomized to the TAU condition will be offered MBCL as well. Primary outcome measure is severity of depressive symptoms according to the Beck Depression Inventory-II (BDI-II) at post-treatment. Secondary outcome measures are presence or absence of DSM-IV depressive disorder, rumination, self-compassion, mindfulness skills, positive affect, quality of life, experiential avoidance and fear of self-compassion. Our study is the first randomized controlled trial to examine the effectiveness of compassion training following MBCT in a recurrently depressed population. ClinicalTrials.gov: NCT02059200, registered 30 January 2014.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics